Table 1.
Group | Arm (Continuous/Stop) | 1 Year | 2 Year | ||
---|---|---|---|---|---|
|
|
||||
Male | Female | Male | Female | ||
Vehicle | Continuous | 22 | 23 | 50 | 50 |
Stop | 20 | 20 | 50 | 50 (49)b | |
2.5 BPA | Continuous | 22 | 22 | 48 | 48 |
Stop | 20 | 22 | 48 | 50 | |
25 BPA | Continuous | 20 | 22 | 48 | 46 |
Stop | 20 | 20 | 48 | 48 | |
250 BPA | Continuous | 24 | 24 | 50 | 50 |
Stop | 20 | 22 | 50 | 50 | |
2500 BPA | Continuous | 20 | 20 | 50 | 50 |
Stop | 20 | 20 | 50 | 50 | |
25,000 BPA | Continuous | 22 | 24 | 46 | 46 |
Stop | 22 | 22 | 46 | 46 | |
0.05 EE2 | Continuous | 26 | 26 | 26 | 26 |
0.50 EE2 | Continuous | 26 | 26 | 26 | 26 |
Animals were allocated to the interim or terminal sacrifice of the continuous or stop dose arms of the study at weaning. There were no same sex litter mates in any treatment group. The original protocol indicated 26 animals/sex/treatment group for the interim sacrifice and 50 animals/sex/BPA treatment group (26 for EE2 groups) for the terminal sacrifice. A shortfall in the number of pups available for the specialty studies resulted in a change such that 20–26 animals/sex/treatment being allocated to the interim sacrifice and any extra pups were allocated to specialty studies.
In this group, one animal assigned was found to have been incorrectly sexed and was discarded on the day of allocation.